Cargando…
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
In recent years, numerous clinical trials for disease modification in Parkinson’s disease (PD) have failed, possibly because of a “one-size-fits all” approach. Alternatively, a precision medicine approach, which customises treatments based on patients’ individual genotype, may help reach disease mod...
Autores principales: | Schneider, Susanne A., Alcalay, Roy N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035220/ https://www.ncbi.nlm.nih.gov/pubmed/31974807 http://dx.doi.org/10.1007/s00415-020-09705-7 |
Ejemplares similares
-
New awakenings: current understanding of sleep dysfunction and its treatment in Parkinson’s disease
por: Keir, Lindsay H. M., et al.
Publicado: (2019) -
Emerging Targeted Therapeutics for Genetic Subtypes of Parkinsonism
por: Schneider, Susanne A., et al.
Publicado: (2020) -
Towards early disease modification of Parkinson’s disease: a review of lessons learned in the Alzheimer field
por: Smedinga, Marthe, et al.
Publicado: (2020) -
A systematic review of local field potential physiomarkers in Parkinson’s disease: from clinical correlations to adaptive deep brain stimulation algorithms
por: van Wijk, Bernadette C. M., et al.
Publicado: (2022) -
Amyotrophic lateral sclerosis: the complex path to precision medicine
por: Talbot, Kevin, et al.
Publicado: (2018)